ATE315104T1 - Glaukom diagnose und behandlung - Google Patents

Glaukom diagnose und behandlung

Info

Publication number
ATE315104T1
ATE315104T1 AT98907455T AT98907455T ATE315104T1 AT E315104 T1 ATE315104 T1 AT E315104T1 AT 98907455 T AT98907455 T AT 98907455T AT 98907455 T AT98907455 T AT 98907455T AT E315104 T1 ATE315104 T1 AT E315104T1
Authority
AT
Austria
Prior art keywords
glaucoma
gene associated
gene
administration
hybridization
Prior art date
Application number
AT98907455T
Other languages
English (en)
Inventor
Mansoor Sarfarazi
Original Assignee
Univ Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/800,036 external-priority patent/US5830661A/en
Application filed by Univ Connecticut filed Critical Univ Connecticut
Application granted granted Critical
Publication of ATE315104T1 publication Critical patent/ATE315104T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Inorganic Insulating Materials (AREA)
  • Magnetic Heads (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Prostheses (AREA)
AT98907455T 1997-02-13 1998-02-12 Glaukom diagnose und behandlung ATE315104T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,036 US5830661A (en) 1997-02-13 1997-02-13 Diagnosis and treatment of glaucoma
US08/926,492 US5962230A (en) 1997-02-13 1997-09-10 Diagnosis and treatment of glaucoma

Publications (1)

Publication Number Publication Date
ATE315104T1 true ATE315104T1 (de) 2006-02-15

Family

ID=27122179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907455T ATE315104T1 (de) 1997-02-13 1998-02-12 Glaukom diagnose und behandlung

Country Status (11)

Country Link
US (2) US5962230A (de)
EP (1) EP0970243B1 (de)
JP (1) JP2001512969A (de)
KR (1) KR20000071083A (de)
CN (1) CN1250484A (de)
AT (1) ATE315104T1 (de)
AU (1) AU724316B2 (de)
CA (1) CA2281000A1 (de)
DE (1) DE69833104D1 (de)
NZ (1) NZ337351A (de)
WO (1) WO1998036098A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050006A2 (en) 1999-02-26 2000-08-31 Chiron Corporation Microemulsions with adsorbed macromoelecules and microparticles
US6127128A (en) * 1999-05-07 2000-10-03 University Of Connecticut Diagnosis of primary congenital glaucoma
AU2002239410B2 (en) 2000-10-31 2008-05-01 Eisai Inc. CYP1B1 nucleic acids and methods of use
US20050069893A1 (en) * 2002-03-01 2005-03-31 Josef Flammer Diagnostic method for glaucoma
CA2566191A1 (en) * 2004-05-11 2005-12-15 Merck & Co., Inc. Process for making n-sulfonated-amino acid derivatives
SG177968A1 (en) * 2007-04-17 2012-02-28 Santen Pharmaceutical Co Ltd Method for determination of progression risk of glaucoma
RU2404253C1 (ru) * 2009-06-22 2010-11-20 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова Федерального агентства по здравоохранению и социальному развитию" СПОСОБ ОБНАРУЖЕНИЯ МУТАЦИИ P369ins В ГЕНЕ CYP1B1
CN111304226A (zh) * 2019-11-21 2020-06-19 福州福瑞医学检验实验室有限公司 一种编码cyp1b1基因突变体的核酸及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606043A (en) * 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
FR2733251B1 (fr) * 1995-04-18 1997-07-04 Inst Nat Sante Rech Med Depistage du glaucome juvenile

Also Published As

Publication number Publication date
AU724316B2 (en) 2000-09-14
WO1998036098A1 (en) 1998-08-20
US6046009A (en) 2000-04-04
AU6325898A (en) 1998-09-08
CA2281000A1 (en) 1998-08-20
CN1250484A (zh) 2000-04-12
KR20000071083A (ko) 2000-11-25
DE69833104D1 (de) 2006-03-30
EP0970243B1 (de) 2006-01-04
EP0970243A1 (de) 2000-01-12
JP2001512969A (ja) 2001-08-28
US5962230A (en) 1999-10-05
NZ337351A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
Das et al. Novel missense mutations and a 288‐bp exonic insertion in PAX9 in families with autosomal dominant hypodontia
Nancarrow et al. Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis
USH2191H1 (en) Identification and mapping of single nucleotide polymorphisms in the human genome
USH2220H1 (en) Identification and mapping of single nucleotide polymorphisms in the human genome
US20020198371A1 (en) Identification and mapping of single nucleotide polymorphisms in the human genome
Asherson et al. Approaches to gene mapping in complex disorders and their application in child psychiatry and psychology
JP2011512163A (ja) 自閉症および自閉症の表現型に関連する遺伝子変化ならびに自閉症の診断および治療に対するその使用方法
MXPA06003828A (es) Uso de polimorfismos geneticos que se asocian con la eficacia del tratamiento de enfermedad inflamatoria.
CN1126496A (zh) 耳毒性耳聋易感性突变的检测方法
Kenney et al. Characterization of the p67phox gene: genomic organization and restriction fragment length polymorphism analysis for prenatal diagnosis in chronic granulomatous disease
DE69833104D1 (de) Glaukom diagnose und behandlung
Zimmerman et al. Exploiting structural differences among heteroduplex molecules to simplify genotyping the DQA1 and DQB1 alleles in human lymphocyte typing
US6566064B1 (en) Method for anticipating sensitivity to medicine for osteoporosis
WO2001018250A3 (en) Single nucleotide polymorphisms in genes
Ichikawa et al. The activation of K-ras gene at an early stage of lung tumorigenesis in mice
DE69816987D1 (de) Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten
WO2000068432A3 (en) Diagnosis of primary congenital glaucoma
Mila et al. Rare variants in the promoter of the fragile X syndrome gene (FMR1)
Jones et al. A salivary amylase transgene is efficiently expressed in liver but not in parotid gland of transgenic mice
CA2425669C (en) Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
EP1100963A2 (de) Polymorphismen des humanen ccr-2 gens
CN115873861B (zh) Pah致病突变体及在制备苯丙酮尿症诊断试剂盒中的应用
FAN et al. Identification of a mutation hotspot in exon 8 of Wilson disease gene by cycle sequencing
JP2005511095A (ja) Ｄ−アミノ酸オキシダーゼのバイアレリック・マーカー及びその用途
RU2006101561A (ru) Способы обнаружения болезни альцгеймера

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties